SIO GENE THERAPIES INC - COMMON (SIOX)

CUSIP: 829399104

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COMMON
Total 13F shares
20,622,653
Share change
+71,134
Total reported value
$56,100,279
Put/Call ratio
92%
Price per share
$2.73
Number of holders
44
Value change
+$339,132
Number of buys
22
Number of sells
27

Quarterly Holders Quick Answers

What is CUSIP 829399104?
CUSIP 829399104 identifies SIOX - SIO GENE THERAPIES INC - COMMON in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SIO GENE THERAPIES INC - COMMON (SIOX) as of Q2 2021

As of 30 Jun 2021, SIO GENE THERAPIES INC - COMMON (SIOX) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,622,653 shares. The largest 10 holders included SUVRETTA CAPITAL MANAGEMENT, LLC, Rubric Capital Management LP, Consonance Capital Management LP, Opaleye Management Inc., VANGUARD GROUP INC, Hudson Bay Capital Management LP, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA INVESTMENTS, LP, GSA CAPITAL PARTNERS LLP, and TWO SIGMA ADVISERS, LP. This page lists 44 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.